Mukka Proteins Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

653.50

244.58

170.77

381.57

303.15

149.20

172.50

Other Operating Income

0.00

Total Operating income

653.50

244.58

170.77

381.57

303.15

149.20

172.50

Raw Material Cost

581.97

280.45

192.85

254.60

341.86

129.23

190.42

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-31.02

-91.78

-63.52

57.32

-120.97

-16.97

-60.14

Employee Cost

10.82

8.94

7.89

8.57

8.43

8.31

6.99

Power Cost

0.00

Manufacturing Expenses

0.00

0.01

0.00

-0.01

0.00

Selling and Distribution Expenses

0.00

Other Expenses

46.29

26.23

19.00

31.92

32.48

19.06

21.11

Total Expenditure (Excl Depreciation)

608.06

223.85

156.22

352.40

261.80

139.63

158.38

Operating Profit (PBDIT) excl Other Income

45.44

20.73

14.55

29.17

41.35

9.57

14.12

Other Income

4.93

6.00

2.56

4.15

5.80

3.14

2.85

Operating Profit (PBDIT)

50.37

26.73

17.11

33.32

47.15

12.71

16.97

Interest

14.56

12.82

11.04

10.32

10.91

8.72

8.13

Exceptional Items

0.00

Gross Profit (PBDT)

35.81

13.91

6.07

23.00

36.24

3.99

8.84

Depreciation

4.03

4.18

3.26

2.82

3.80

3.76

3.12

Profit Before Tax

34.62

9.28

2.36

20.10

32.97

1.05

5.54

Tax

7.37

2.39

0.77

6.10

6.17

-0.42

0.28

Provisions and contingencies

0.00

Profit After Tax

24.41

7.33

2.04

14.09

26.28

0.64

5.45

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

24.41

7.33

2.04

14.09

26.28

0.64

5.45

Share in Profit of Associates

2.84

-0.45

-0.09

0.52

0.83

-0.19

Minority Interest

3.51

1.01

0.07

0.41

0.54

-0.61

1.03

Other related items

0.00

Consolidated Net Profit

23.75

5.88

1.52

13.59

26.26

2.08

4.23

Equity Capital

30.00

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

0.79

0.2

0.05

0.45

0.88

0.07

0.14

Diluted Earnings per share

0.79

0.2

0.05

0.45

0.88

0.07

0.14

Operating Profit Margin (Excl OI)

7.16%

8.78%

8.82%

7.84%

13.96%

6.61%

8.47%

Gross Profit Margin

5.64%

5.89%

3.68%

6.18%

12.23%

2.75%

5.3%

PAT Margin

4.29%

2.91%

0.96%

3.76%

9.05%

1.01%

3.16%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 167.19% vs 43.22% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 303.91% vs 286.84% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 119.20% vs 42.47% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 13.57% vs 16.12% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Mukka Proteins With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

653.50

109.51

543.99

496.75%

Other Operating Income

0.00

Total Operating income

653.50

109.51

543.99

496.75%

Raw Material Cost

581.97

76.94

505.03

656.39%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-31.02

-4.83

-26.19

-542.24%

Employee Cost

10.82

7.12

3.70

51.97%

Power Cost

0.00

Manufacturing Expenses

0.00

5.27

-5.27

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

46.29

14.79

31.50

212.98%

Total Expenditure (Excl Depreciation)

608.06

99.29

508.77

512.41%

Operating Profit (PBDIT) excl Other Income

45.44

10.22

35.22

344.62%

Other Income

4.93

0.49

4.44

906.12%

Operating Profit (PBDIT)

50.37

10.71

39.66

370.31%

Interest

14.56

1.12

13.44

1,200.00%

Exceptional Items

0.00

Gross Profit (PBDT)

35.81

9.59

26.22

273.41%

Depreciation

4.03

1.19

2.84

238.66%

Profit Before Tax

34.62

8.40

26.22

312.14%

Tax

7.37

2.42

4.95

204.55%

Provisions and contingencies

0.00

Profit After Tax

24.41

5.98

18.43

308.19%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

24.41

5.98

18.43

308.19%

Share in Profit of Associates

2.84

-2.10

4.94

235.24%

Minority Interest

3.51

0.00

3.51

Other related items

0.00

Consolidated Net Profit

23.75

3.88

19.87

512.11%

Equity Capital

30.00

5.51

24.49

444.46%

Face Value

1.00

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

0.79

7.04

-6.25

-88.78%

Diluted Earnings per share

0.79

0.28

0.51

182.14%

Operating Profit Margin (Excl OI)

7.16%

9.33%

0.00

-2.17%

Gross Profit Margin

5.64%

8.76%

0.00

-3.12%

PAT Margin

4.29%

5.46%

0.00

-1.17%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 653.50 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 167.19% vs 43.22% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 115.57% vs -41.36% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 23.75 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 303.91% vs 286.84% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -9.56% vs 150.81% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 45.44 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 119.20% vs 42.47% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 9.89% vs 119.01% in Dec 2024

Quarterly - Interest

Interest 14.56 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 13.57% vs 16.12% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 33.46% vs 77.40% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.16%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024